Edition:
India

Dare Bioscience Inc (DARE.OQ)

DARE.OQ on NASDAQ Stock Exchange Capital Market

0.83USD
2:29am IST
Change (% chg)

$-0.07 (-7.90%)
Prev Close
$0.90
Open
$0.90
Day's High
$0.92
Day's Low
$0.82
Volume
196,572
Avg. Vol
33,163
52-wk High
$3.25
52-wk Low
$0.61

Latest Key Developments (Source: Significant Developments)

Daré Bioscience Enters Into Deal To Buy Microchips Biotech
Monday, 11 Nov 2019 

Nov 11 (Reuters) - Dare Bioscience Inc ::DARÉ BIOSCIENCE ENTERS INTO AGREEMENT TO ACQUIRE MICROCHIPS BIOTECH INCLUDING ITS FIRST-IN-CLASS WIRELESS, USER-CONTROLLED DRUG DELIVERY PLATFORM.DARE BIOSCIENCE - MICROCHIPS' CASH BALANCE AT CLOSING IS EXPECTED TO BE ABOUT $6.9 MILLION, ABOUT $5.7 MILLION AFTER PAYMENT OF ONE-TIME DEAL RELATED EXPENSES.DARE BIOSCIENCE- MAY PAY UP TO $46.5 MILLION IN CONTINGENT CONSIDERATION FOR PRODUCT DEVELOPMENT, REGULATORY AND FUNDING MILESTONES.DARE BIOSCIENCE INC - MAY PAY UP TO $55.0 MILLION IN CONTINGENT CONSIDERATION FOR COMMERCIAL DEVELOPMENT MILESTONE PAYMENTS.  Full Article

Dare Bioscience Says Qtrly Loss Per Share $0.29
Thursday, 15 Aug 2019 

Aug 14 (Reuters) - Dare Bioscience Inc ::DARÉ BIOSCIENCE REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS AND COMPANY UPDATE.QTRLY LOSS PER SHARE $0.29.  Full Article

Daré Bioscience Appoints William Rastetter As Chairman Of Its Board Of Directors
Monday, 15 Jul 2019 

July 15 (Reuters) - Dare Bioscience Inc ::DARÉ BIOSCIENCE ANNOUNCES APPOINTMENT OF DR. WILLIAM H. RASTETTER AS CHAIRMAN OF THE BOARD OF DIRECTORS.DARE BIOSCIENCE INC - WILLIAM RASTETTER WAS APPOINTED CHAIRMAN OF ITS BOARD OF DIRECTORS EFFECTIVE JULY 11.  Full Article

Dare Bioscience Files For $1.6 Mln Common Stock Offering - SEC Filing
Saturday, 1 Jun 2019 

May 31 (Reuters) - Dare Bioscience Inc ::DARE BIOSCIENCE INC - FILES FOR $1.6 MILLION COMMON STOCK OFFERING - SEC FILING.  Full Article

Daré Bioscience Reports Qtrly Loss Per Share $0.27
Wednesday, 15 May 2019 

May 14 (Reuters) - Dare Bioscience Inc ::DARÉ BIOSCIENCE REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND COMPANY UPDATE.DARE BIOSCIENCE INC - QTRLY LOSS PER SHARE $0.27.DARE BIOSCIENCE INC - AS OF MARCH 31, 2019, CASH AND CASH EQUIVALENTS WERE APPROXIMATELY $3.5 MILLION.  Full Article

Daré Bioscience Prices Underwritten Public Offering Of Common Stock
Tuesday, 9 Apr 2019 

April 9 (Reuters) - Dare Bioscience Inc ::DARÉ BIOSCIENCE, INC. PRICES UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 4.58 MILLION COMMON SHARES PRICED AT $1.10PER SHARE.  Full Article

Daré Bioscience Says Intends To Communicate With U.S. FDA In Mid-2018 Regarding Phase 2b Study Of Topical Sildenafil
Tuesday, 3 Apr 2018 

April 2 (Reuters) - Dare Bioscience Inc ::DARÉ BIOSCIENCE, INC. REPORTS 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.DARE BIOSCIENCE - INTENDS TO COMMUNICATE WITH U.S. FDA IN MID-2018 REGARDING PHASE 2B STUDY OF TOPICAL SILDENAFIL.ANTICIPATES COMMENCING A PHASE 2B STUDY OF TOPICAL SILDENAFIL IN Q4 OF 2018.  Full Article

CVI Investments Reports 8.8 Pct Passive Stake In Dare Bioscience As Of Feb 13
Thursday, 22 Feb 2018 

Feb 22 (Reuters) - CVI Investments :CVI INVESTMENTS REPORTS AN 8.8 PERCENT PASSIVE STAKE IN DARÉ BIOSCIENCE AS OF FEB 13- SEC FILING.  Full Article

Dare Bioscience Inc To Raise About $10.25 Mln
Tuesday, 13 Feb 2018 

Feb 13 (Reuters) - Dare Bioscience Inc ::DARÉ BIOSCIENCE, INC. TO RAISE APPROXIMATELY $10.25 MILLION.DARE BIOSCIENCE -EACH SHARE BEING SOLD TOGETHER WITH WARRANT TO BUY UP TO .70 OF A SHARE OF COMMON STOCK, AT EXERCISE PRICE OF $3.00/SHARE.  Full Article

Daré Bioscience Announces Proposed Public Offering Of Common Stock
Tuesday, 13 Feb 2018 

Feb 13 (Reuters) - Dare Bioscience Inc ::DARÉ BIOSCIENCE, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.DARE BIOSCIENCE - INTENDS TO OFFER PRIMARY SHARES OF ITS COMMON STOCK AND WARRANTS TO PURCHASE SHARES OF ITS COMMON STOCK IN A PUBLIC OFFERING.  Full Article